| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An update on the role of PET/CT and PET/MRI in ovarian cancer
|
Khiewvan, Benjapa
|
|
2017
|
44 |
6 |
p. 1079-1091
|
article
|
| 2 |
Atlas of Anatomy - Third Edition. Anne M. Gilroy and Brian R. MacPherson (Eds) On the basis of the work of Michael Schuenke, Erik Schulte and Udo Schumaker
|
Melluso, Gennaro
|
|
2017
|
44 |
6 |
p. 1102-1103
|
article
|
| 3 |
213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer
|
Sathekge, Mike
|
|
2017
|
44 |
6 |
p. 1099-1100
|
article
|
| 4 |
Central noradrenaline transporter availability in highly obese, non-depressed individuals
|
Hesse, Swen
|
|
2017
|
44 |
6 |
p. 1056-1064
|
article
|
| 5 |
Changes in dorsolateral prefrontal connectivity after rTMS in treatment-resistant depression: a brain perfusion SPECT study
|
Richieri, Raphaëlle
|
|
2017
|
44 |
6 |
p. 1051-1055
|
article
|
| 6 |
Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer
|
Schmuck, Sebastian
|
|
2017
|
44 |
6 |
p. 960-968
|
article
|
| 7 |
Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy
|
Piccardo, Arnoldo
|
|
2016
|
44 |
6 |
p. 926-934
|
article
|
| 8 |
18F-FDG PET/MRI in patients suffering from lymphoma: how much MRI information is really needed?
|
Kirchner, Julian
|
|
2017
|
44 |
6 |
p. 1005-1013
|
article
|
| 9 |
68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour
|
Uprimny, Christian
|
|
2017
|
44 |
6 |
p. 941-949
|
article
|
| 10 |
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
|
Fendler, Wolfgang P.
|
|
2017
|
44 |
6 |
p. 1014-1024
|
article
|
| 11 |
Head-to-head comparison between 18F-FDOPA PET/CT and MR/CT angiography in clinically recurrent head and neck paragangliomas
|
Heimburger, Céline
|
|
2017
|
44 |
6 |
p. 979-987
|
article
|
| 12 |
Imaging the DNA damage response with PET and SPECT
|
Knight, James C.
|
|
2017
|
44 |
6 |
p. 1065-1078
|
article
|
| 13 |
In memoriam Professor Jan van der Schoot (1927–2017)
|
Busemann Sokole, Ellinor
|
|
2017
|
44 |
6 |
p. 1104-1105
|
article
|
| 14 |
Juliano Cerci, Stefano Fanti, Dominique Delbeke (Eds): Oncological PET/CT with Histological Confirmation
|
Piscopo, Valentina
|
|
2017
|
44 |
6 |
p. 1101
|
article
|
| 15 |
Measuring the actual I-131 thyroid uptake curve with a collar detector system: a feasibility study
|
Brinks, Peter
|
|
2016
|
44 |
6 |
p. 935-940
|
article
|
| 16 |
Measuring the actual I-131 thyroid uptake curve with a collar detector system: a feasibility study
|
Brinks, Peter
|
|
|
44 |
6 |
p. 935-940
|
article
|
| 17 |
Monitoring metastatic lesions in TENIS, initiating multi-targeted tyrosine kinase inhibitors and follow-up: should the newer FDG PET-CT quantitative indices be the defining objective parameter in clinical trials?
|
Basu, Sandip
|
|
2017
|
44 |
6 |
p. 1092-1094
|
article
|
| 18 |
Neural correlates of the popular music phenomenon: evidence from functional MRI and PET imaging
|
Chen, Qiaozhen
|
|
2017
|
44 |
6 |
p. 1033-1041
|
article
|
| 19 |
PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans
|
Hillmer, Ansel T.
|
|
2017
|
44 |
6 |
p. 1042-1050
|
article
|
| 20 |
Post-treatment PET/CT and p16 status for predicting treatment outcomes in locally advanced head and neck cancer after definitive radiation
|
Awan, Musaddiq J.
|
|
2017
|
44 |
6 |
p. 988-997
|
article
|
| 21 |
Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging
|
Zanotti-Fregonara, Paolo
|
|
2017
|
44 |
6 |
p. 1095-1096
|
article
|
| 22 |
Radioiodine treatment after surgery for differentiated thyroid cancer: a reasonable option
|
Clerc, Jérôme
|
|
2017
|
44 |
6 |
p. 918-925
|
article
|
| 23 |
Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers
|
Takeuchi, Satoshi
|
|
2016
|
44 |
6 |
p. 969-978
|
article
|
| 24 |
Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095
|
Afshar-Oromieh, Ali
|
|
2017
|
44 |
6 |
p. 950-959
|
article
|
| 25 |
Test–retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging
|
Kaller, Simon
|
|
2017
|
44 |
6 |
p. 1025-1032
|
article
|
| 26 |
The added value of SPECT-CT for the identification of sentinel lymph nodes in early stage oral cancer
|
Toom, Inne J. den
|
|
2017
|
44 |
6 |
p. 998-1004
|
article
|
| 27 |
The gross picture: intraindividual tumour heterogeneity in a patient with nonsecretory multiple myeloma
|
Lapa, Constantin
|
|
2017
|
44 |
6 |
p. 1097-1098
|
article
|
| 28 |
The “reset button” revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients
|
Verburg, Frederik A.
|
|
2017
|
44 |
6 |
p. 915-917
|
article
|
Journal description